Methods of treating subjects having diabetes with chronic kidney disease
AssigneePoxel
InventorsBill Symonds, Steve Piscitelli, Karen Segal, Ruby Holder, Sophie Bozec, Sébastien Bolze, Pascale Fouqueray, Christophe Arbet-Engels, Julie Dubourg, Paul Strumph, Brandon Dale Swift, Margaret Smith Fletcher
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed to a method of treating prediabetes or type 1 or type 2 diabetes mellitus comprising administering to a subject in need thereof an effective amount of imeglimin, wherein the subject has chronic kidney disease.
Claims20
A method of treating type 2 diabetes mellitus comprising administering to a subject in need thereof an effective amount of imeglimin, wherein the subject has stage 3B or stage 4 chronic kidney disease.
A method of improving glycemic control in a subject having type 2 diabetes comprising administering to the subject in need thereof an effective amount of imeglimin, wherein the subject has stage 3B or stage 4 chronic kidney disease.
Dependencies are inferred from the claim text.